FKBP1AP3

Across TCGA pan-cancer cohorts, FKBP1AP3 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated FKBP1AP3 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher FKBP1AP3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FKBP1AP3 expression acts as an unfavorable survival marker, although some lineages such as UCS show a favorable association.

BLCA, BRCA, and MESO are the cancer types where FKBP1AP3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.282	0.533	<.001	90	view →
BRCA	DFS	Tertile	II,III,IV	0.829	0.898	.016	57	view →
MESO	OS	Tertile	II,III,IV	0.306	0.591	.001	45	view →
PAAD	OS	Tertile	All	0.169	0.510	.008	36	view →
THCA	OS	Tertile	II,III,IV	0.747	0.937	<.001	27	view →
UCEC	OS	Tertile	All	0.356	0.715	.022	24	view →
CHOL	DFS	Tertile	All	0.037	0.497	.004	18	view →
DLBC	DFS	Tertile	II,III,IV	0.416	0.878	.021	18	view →
UCS	DFS	Tertile	IV	0.996	0.570	.039	18	view →
STAD	OS	Quartile	All	0.469	0.786	.016	11	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	9	view →
LUSC	OS	Quartile	III,IV	0.206	0.818	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

FKBP1AP3–BLCA (DFS)

Open the BLCA breakdown →